フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Pharming Group to report second quarter and first half 2023 financial results on August 3 PR Newswire LEIDEN...
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 6-KREPORT OF FOREIGN PRIVATE ISSUERPURSUANT TO RULE 13a-16 OR...
Pharming announces sale of priority review voucher PR Newswire LEIDEN, The Netherlands, June 1, 2023 LEIDEN...
Pharming Group to attend the following Investor Conferences in June PR Newswire LEIDEN, The Netherlands, May...
Pharming Group reports on results of the 2023 Annual General Meeting of Shareholders PR Newswire LEIDEN, The Netherlands, May 17, 2023 LEIDEN...
Pharming Group reports financial results for the first quarter of 2023 PR Newswire LEIDEN, Netherlands, May...
Pharming to attend the H.C. Wainwright BioConnect Investor Conference 2023 PR Newswire LEIDEN, Netherlands...
Pharming to attend the Van Lanschot Kempen Life Sciences Conference 2023 PR Newswire LEIDEN, Netherlands...
Notice of First Quarter 2023 Results PR Newswire LEIDEN, Netherlands, April 19, 2023 LEIDEN, Netherlands...
Pharming to present at the 22nd Annual Needham Virtual Healthcare Conference 2023 PR Newswire LEIDEN...
Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S. PR...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約